+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Autoimmune Disease Diagnostics Market by Product (Consumables & Assay Kits, Instruments), Test (Autoantibodies & Immunologic Test, Inflammatory Markers, Routine Laboratory Tests), Sample Type, Indication, End Users - Global Forecast 2025-2030- Product Image
Autoimmune Disease Diagnostics Market by Product (Consumables & Assay Kits, Instruments), Test (Autoantibodies & Immunologic Test, Inflammatory Markers, Routine Laboratory Tests), Sample Type, Indication, End Users - Global Forecast 2025-2030- Product Image
Sale

Autoimmune Disease Diagnostics Market by Product (Consumables & Assay Kits, Instruments), Test (Autoantibodies & Immunologic Test, Inflammatory Markers, Routine Laboratory Tests), Sample Type, Indication, End Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5014101
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The autoimmune disease diagnostics market is undergoing rapid transformation as health systems prioritize early detection, precision diagnostics, and operational efficiency. Senior decision-makers face evolving industry complexities, with the interplay of technology, supply chains, and regulatory changes shaping tomorrow’s diagnostic strategies.

Market Snapshot: Autoimmune Disease Diagnostics Market Growth

The autoimmune disease diagnostics market grew from USD 5.80 billion in 2024 to USD 6.22 billion in 2025. With demand rising for accurate and timely autoimmune detection, the sector is set to maintain strong momentum, expanding at a CAGR of 7.38%. By 2030, projected revenues are expected to reach USD 8.90 billion. Companies are intensifying their focus on innovation as diagnostic accuracy, technology integration, and supply chain resilience form the foundation for continued growth and global competitiveness.

Scope & Segmentation

This report provides in-depth analysis across the full value chain of the autoimmune disease diagnostics landscape.

  • Product Categories: Consumables & assay kits, instruments
  • Test Types: Autoantibodies & immunologic test, inflammatory markers, routine laboratory tests
  • Sample Types: Blood, saliva, urine
  • Indications: Organ-specific autoimmune disease diagnostics (e.g., Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis, Type 1 diabetes) and systemic autoimmune disease diagnostics (e.g., rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis)
  • End Users: Ambulatory care centers, diagnostic laboratories, hospitals & clinics, research institutions
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Saudi Arabia, South Africa and other key countries), Asia-Pacific (including China, India, Japan, Australia, Singapore and additional markets)
  • Key Companies: Abbott Laboratories, AESKU.GROUP GmbH & Co. KG, Bio-Rad Laboratories, Inc., BioAgilytix Labs, Biogenuix Medsystems Private Limited, bioMerieux SA, Danaher Corporation, DSS Imagetech Pvt. Ltd., Exagen Inc., F. Hoffmann-La Roche Ltd., Grifols, S.A, Hemagen Diagnostics, Inc., Labcorp Holdings Inc., Medical & Biological Laboratories Co. Ltd, Menarini Group, Merck KGaA, Progentec Diagnostics, Inc., Quest Diagnostics, Revvity, Inc., RSR Limited, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech PLC, Werfen Group
  • Technologies: Immunoassay platforms, molecular diagnostics, digital health integration, artificial intelligence, microfluidics, multiplex testing, next-generation sequencing, point-of-care solutions

Key Takeaways for Decision-Makers

  • Technological convergence—including AI and molecular platforms—is elevating diagnostic precision and expanding clinical applications.
  • Strategic alliances among diagnostics and biotech firms are streamlining assay innovation, regulatory pathways, and scalability.
  • Regional disparities in adoption and infrastructure persist, prompting tailored market-entry and product development strategies for stakeholders.
  • Point-of-care and multiplex platforms are increasing testing accessibility, supporting earlier diagnosis and improved resource utilization.
  • Supply chain resilience and cost management are moving to the forefront as providers address procurement pressures and tariff fluctuations.
  • A service-driven approach—offering integrated installation, training, and analytics—differentiates market leaders and accelerates end-user adoption.

Tariff Impact: United States 2025 Policies Reshape Supply Chains

Revised U.S. tariff policies in 2025 have affected costs throughout the autoimmune diagnostics sector, influencing manufacturers’ sourcing and pricing strategies. Stakeholders responded with new domestic manufacturing investments and local supplier partnerships to stabilize pricing and maintain uninterrupted access. The tariff environment is prompting laboratories and providers to adopt demand forecasting and transparent procurement protocols to mitigate supply risks and budgetary pressures.

Methodology & Data Sources

This report is based on comprehensive primary interviews with laboratory directors, clinicians, technologists, and regulatory specialists, combined with secondary data from leading journals, corporate reports, and regulatory filings. Strict data validation, triangulation, and scenario analysis protocols ensure accuracy, applicability, and credibility for strategic planning within the autoimmune disease diagnostics market.

Why This Report Matters

  • Enables accurate market positioning and investment by mapping segmented industry dynamics, emerging technologies, and partnership opportunities.
  • Provides intelligence on regulatory and supply chain shifts, supporting risk mitigation and agile operational planning.
  • Equips leaders with actionable insights to drive strategic growth, technology adoption, and patient-centered innovation across diverse healthcare settings.

Conclusion

The autoimmune disease diagnostics landscape is defined by innovation, collaboration, and evolving operational frameworks. Decision-makers who embrace these trends are poised to unlock value, strengthen market presence, and improve patient outcomes amid ongoing change.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rise of telemedicine enabled home based autoimmune disease testing kits integrated with smartphone connectivity features
5.2. Surge in adoption of digital health platforms for remote ordering and interpretation of autoimmune diagnostic tests
5.3. Expansion of personalized proteomic and metabolomic biomarker panels for predictive type 1 diabetes diagnostics
5.4. Implementation of liquid biopsy based cell free DNA methylation assays for monitoring multiple sclerosis treatment efficacy
5.5. Development of point of care multiplex biomarker testing devices for rapid autoimmune diagnosis in clinical settings
5.6. Integration of artificial intelligence algorithms in immunoassay analysis for improved diagnostic precision
5.7. Adoption of next generation sequencing autoantibody panels for early rheumatoid and lupus detection
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Autoimmune Disease Diagnostics Market, by Product
8.1. Introduction
8.2. Consumables & Assay Kits
8.3. Instruments
9. Autoimmune Disease Diagnostics Market, by Test
9.1. Introduction
9.2. Autoantibodies & Immunologic Test
9.3. Inflammatory Markers
9.4. Routine Laboratory Tests
10. Autoimmune Disease Diagnostics Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Saliva
10.4. Urine
11. Autoimmune Disease Diagnostics Market, by Indication
11.1. Introduction
11.2. Organ-Specific Autoimmune Disease Diagnostics
11.2.1. Graves’ Disease
11.2.2. Hashimoto’s Thyroiditis
11.2.3. Multiple Sclerosis
11.2.4. Type 1 Diabetes
11.3. Systemic Autoimmune Disease Diagnostics
11.3.1. Rheumatoid Arthritis (RA)
11.3.2. Systemic Lupus Erythematosus (SLE)
11.3.3. Systemic Sclerosis (Scleroderma)
12. Autoimmune Disease Diagnostics Market, by End Users
12.1. Introduction
12.2. Ambulatory Care Centers
12.3. Diagnostic Laboratories
12.4. Hospitals & Clinics
12.5. Research Institutions
13. Americas Autoimmune Disease Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Autoimmune Disease Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. AESKU.GROUP GmbH & Co. KG
16.3.3. Bio-Rad Laboratories, Inc.
16.3.4. BioAgilytix Labs
16.3.5. Biogenuix Medsystems Private Limited
16.3.6. bioMerieux SA
16.3.7. Danaher Corporation
16.3.8. DSS Imagetech Pvt. Ltd.
16.3.9. Exagen Inc.
16.3.10. F. Hoffmann-La Roche Ltd.
16.3.11. Grifols, S.A
16.3.12. Hemagen Diagnostics, Inc.
16.3.13. Labcorp Holdings Inc.
16.3.14. Medical & Biological Laboratories Co. Ltd
16.3.15. Menarini Group
16.3.16. Merck KGaA
16.3.17. Progentec Diagnostics, Inc.
16.3.18. Quest Diagnostics
16.3.19. Revvity, Inc.
16.3.20. RSR Limited
16.3.21. Siemens Healthineers AG
16.3.22. Thermo Fisher Scientific Inc.
16.3.23. Trinity Biotech PLC
16.3.24. Werfen Group
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ROUTINE LABORATORY TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ROUTINE LABORATORY TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GRAVES’ DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GRAVES’ DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HASHIMOTO’S THYROIDITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HASHIMOTO’S THYROIDITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS (RA), BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS (RA), BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC SCLEROSIS (SCLERODERMA), BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC SCLEROSIS (SCLERODERMA), BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 98. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 99. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 100. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 101. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 106. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 107. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 108. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 109. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 110. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 112. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 113. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 114. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 115. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 184. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 185. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 186. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 187. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 192. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 193. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 194. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 195. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 196. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 198. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 199. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 200. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 201. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 206. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 207. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 208. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 209. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 210. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 225. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 226. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 227. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 228. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 229. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 230. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 231. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 234. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 235. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 236. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 237. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 238. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 240. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 241. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 242. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 243. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 248. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 249. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 250. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 251. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 252. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ORGAN-SPECIFIC AUTOIMMUNE DISEASE DIAGNO

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • AESKU.GROUP GmbH & Co. KG
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix Labs
  • Biogenuix Medsystems Private Limited
  • bioMerieux SA
  • Danaher Corporation
  • DSS Imagetech Pvt. Ltd.
  • Exagen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Grifols, S.A
  • Hemagen Diagnostics, Inc.
  • Labcorp Holdings Inc.
  • Medical & Biological Laboratories Co. Ltd
  • Menarini Group
  • Merck KGaA
  • Progentec Diagnostics, Inc.
  • Quest Diagnostics
  • Revvity, Inc.
  • RSR Limited
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • Werfen Group

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.22 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.9 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report by Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), Product, Test Type, End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report by Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), Product, Test Type, End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 129 Pages
  • Global
From
Autoimmune Disease Diagnostics Market by Product, Test Type, Technology, Disease Type, End-user - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025-2035 - Product Image

Autoimmune Disease Diagnostics Market by Product, Test Type, Technology, Disease Type, End-user - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025-2035

  • Report
  • 180 Pages
  • Global
From
Autoimmune Disease Diagnostics Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Image

Autoimmune Disease Diagnostics Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • 150 Pages
  • Global
From
Autoimmune Disease Diagnostics Market (By Disease, Test Types, Country Analysis), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2032 - Product Image

Autoimmune Disease Diagnostics Market (By Disease, Test Types, Country Analysis), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2032

  • Report
  • 195 Pages
  • Global
From
Autoimmune Disease Diagnostics Market Global Report by Product, Types, Indication, End-Users, Countries and Company Analysis 2025-2033 - Product Image

Autoimmune Disease Diagnostics Market Global Report by Product, Types, Indication, End-Users, Countries and Company Analysis 2025-2033

  • Report
  • 210 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.